MENU
+Compare
PCVX
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$32.23
Change
-$5.53 (-14.65%)
Capitalization
4.15B

PCVX Vaxcyte Forecast, Technical & Fundamental Analysis

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases... Show more

PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PCVX with price predictions
Mar 31, 2025

PCVX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 31, 2025

PCVX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where PCVX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for PCVX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PCVX advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PCVX as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PCVX turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PCVX entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.255) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.565).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PCVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PCVX is expected to report earnings to rise 3.92% to -105 cents per share on May 12

Vaxcyte PCVX Stock Earnings Reports
Q1'25
Est.
$-1.06
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.27
Q2'24
Missed
by $0.12
Q1'24
Beat
by $0.28
The last earnings report on February 25 showed earnings per share of -101 cents, beating the estimate of -112 cents. With 8.89M shares outstanding, the current market capitalization sits at 4.15B.
A.I. Advisor
published General Information

General Information

a company which engages in development of vaccines for infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
825 Industrial Road
Phone
+1 650 837-0111
Employees
254
Web
https://www.vaxcyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MTUM203.541.41
+0.70%
iShares MSCI USA Momentum Factor ETF
SPXV60.380.33
+0.55%
ProShares S&P 500® ex-Health Care
STXG40.270.22
+0.54%
Strive 1000 Growth ETF
FFEB48.930.14
+0.29%
FT Vest US Equity Buffer ETF Feb
JUCY22.890.06
+0.26%
Aptus Enhanced Yield ETF

PCVX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-45.64%
ORKA - PCVX
60%
Loosely correlated
-17.92%
LOGC - PCVX
45%
Loosely correlated
+0.43%
RXRX - PCVX
42%
Loosely correlated
-8.95%
DNLI - PCVX
42%
Loosely correlated
-8.02%
DYN - PCVX
41%
Loosely correlated
-8.65%
More